Life Sciences Sector Plan Sets UK on Global Growth Track
The UK Life Sciences Sector Plan drives R&D growth, NHS innovation, and clinical trials to place the UK among the top 3 global biotech leaders by 2035.
Highly Customized Treatments to Offer Specialized Care to UK
Highly customized treatments to offer specialized care to UK will work towards cancer treatments that are time-sensitive and also bring care near to patient.
Surgical Stapling Devices Market to Reach $7.8 Bn by 2035
The rising incidences of chronic diseases, robot-assisted surgeries are driving the surgical stapling devices segment which is eyeing to reach $7.8 Bn by 2035.